Advertisement
Screener

Cognition Therapeutics, Inc. (CGTX) ROA

Cognition Therapeutics, Inc. (CGTX) ROA

  • 2026-06-30: ROA -43.13%.
  • 2026-03-31: ROA -54.17%.
  • 2025-12-31: ROA -48.54%.
  • 2025-09-30: ROA -64.49%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-43.13%
2026-03-31-54.17%
2025-12-31-48.54%
2025-09-30-64.49%
2025-06-30-168.14%
2025-03-31-141.70%
2024-12-31-112.36%
2024-09-30-124.26%
2024-06-30-90.44%
2024-03-31-74.04%
2023-12-31-73.34%
2023-09-30-58.88%
2023-06-30-51.65%
2023-03-31-51.97%
2022-12-31-42.43%
2022-09-30-43.98%
2022-06-30-37.94%
2022-03-31-26.88%
2021-12-31-19.81%
2021-09-30-46.64%
2020-12-31-110.11%

Annual ROA

DateROA
2025-12-31-48.54%
2024-12-31-112.36%
2023-12-31-73.34%
2022-12-31-42.43%
2021-12-31-19.81%
2020-12-31-110.11%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Vaxart, Inc. (VXRT)United States$0.080B3.84
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41